⌘K

Home/Filings/4/0001127602-09-012685

4//SEC Filing

BIOCRYST PHARMACEUTICALS INC 4

Accession 0001127602-09-012685

$BCRXCIK 0000882796operating

View on SEC.gov Company Profile

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 12:57 PM ET

Size

10.6 KB

Accession

0001127602-09-012685

Insider Transaction Report

Form 4

Period: 2009-04-30

BIOCRYST PHARMACEUTICALS INCBCRX

Biggar Stephen R

Director

Transactions

Award
Non-Qualified Stock Option
2009-04-30$3.96/sh+15,000$59,400→ 15,000 total
Exercise: $3.96From: 2009-05-30Exp: 2019-04-30→ Common Stock (15,000 underlying)

Holdings

Stock Option
Exercise: $12.26From: 2006-06-17Exp: 2016-05-17→ Common Stock (15,000 underlying)
15,000
Stock Option
Exercise: $9.82From: 2005-11-03Exp: 2015-10-03→ Common Stock (5,833 underlying)
5,833

Footnotes (3)

[F1]Automatic non-employee director grant
[F2]Vest @ 1/12 per month over 12 months
[F3]Vests monthly over a period of 7 months.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000882796

Filing Metadata

Form type: 4
Filed: May 31, 8:00 PM ET
Accepted: Jun 1, 12:57 PM ET
Size: 10.6 KB

View on SEC.gov